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ABSTRACT
Hantavirosis is a zoonotic infection transmitted mainly by rodents. In Peru, a lethality of 40–60% is
calculated in inhabitants of the Peruvian Amazon jungle, especially in Loreto. Despite this, this disease
continues to be under-diagnosed despite the fact that it represents a serious problem for public health
in Latin America. We present a sistematic revision of case reports and seris of cases of Hantavirus
infection in the Peruvian jungle. The most important characteristic of the cases presented are mean
age 25.7 years, predominance of females (5/6), clinical presentation of headache, myalgias, nausea and
vomiting (6/6) and unfavorable evolution to acute respiratory to acute respiratory distress (ARDS), renal
failure, septic shock and multiple organ failure in 3of the cases presented.
Key words: Hantavirus; Tropical climate; Rodents (source: MeSH NLM).

RESUMEN
La hantavirosis es una infección zoonótica transmitida principalmente por roedores. En el Perú, se
calcula una letalidad del 40–60% en pobladores de la selva amazónica peruana, especialmente en
Loreto. A pesar de ello, esta enfermedad continúa siendo sub-diagnosticada a pesar que representa
un problema serio para la salud pública en Latinoamérica. Presentamos una revisión sistemática
de reportes y series de casos de infección por Hantavirus procedentes de la selva peruana. Las
características más importantes de los casos presentados son: media de edad 25.7 años, predominio
del sexo femenino (5/6), presentación clínica de cefalea, mialgias, nausea y vómitos (6/6), y evolución
desfavorable a distrés respiratorio agudo (SDRA), falla renal, shock séptico y falla multiorgánica en 3 de
los casos presentados.
Palabras clave: Hantavirus; Clima tropical; Roedores (fuente: DeCS BIREME).
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INTRODUCTION

METHODS

Hantavirus are single-stranded, negative-sense, RNA
viruses, they present an envelope and belong to the
Orthohantavirus genus (Hantaviridae family)(1).

Systematic review of reports and case series on
Hantavirus disease in patients from the Peruvian
Amazon during the period from 2010-2020.

Over 90 species have been described and found in
shrews, bats and rodents. The latter reservoir has
over 20 species known to be pathogens of human
beings, with two different clinical presentations:
hemorrhagic fever with renal syndrome (HFRS)
in Europe and Asia, while in the Americas, the
Hantavirus cardiopulmonary syndrome (HCPS) with
a death rate of 35%(1,2).

Systematic review

The Hantavirus causal agent Andes type of HCPS has
an incubation period of 10 to 40 days, a prodromal
phase of 2 to 6 days characterized by headache,
fever, myalgias and gastrointestinal symptoms
(abdominal pain, nauseas, vomiting, and diarrhea),
and a cardiopulmonary phase with acute respiratory
insufficiency, associated with dyspnea and cough,
due to ta plasma filtration at the alveolar level and
pulmonary edema, however, the severe cases may
develop myocardial dysfunction with low cardiac
output and arterial hypotension(2,3,4).
Human transmission occurs through viral aerosol
inhalation generated from the excrements, urine,
and saliva of infected rodents. Likewise, person to
person transmission has been described, with ANDV
as the first and only report in South America, which
was corroborated through an outbreak in southeast
Argentina(1,3,4).
In Peru, between 1996 and 1998 in the city of Iquitos,
Hantavirus seropositive cases were reported in
humans for the variants Hanta (HTNV), Sin nombre
virus (SNV) and Rio Marmore virus (RIOMV). However,
in 2011, the disease was confirmed in humans
from two cases in the region of Loreto(5,6). In both
cases IgM antibodies were detected through ELISA
test and the diagnosis were performed through
RT-PCR NESTED technique in serum confirming
Hantavirus cardiopulmonary syndrome (HCPS)(5,6).
However, disease by Hantavirus continues to be a
sub-diagnosed condition despite the serious public
health problems it represents in Latin America(7).
For this reason, we are presenting 6 published cases
of Hantavirus infection in the Peruvian jungle. The
objective is to recognize the clinical signs and causal
agent, perform an early and opportune diagnosis,
adequate treatment and adopt preventive measures.
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An systematic electronic search between the
period f 2010-2020 was performed in the following
databases: Scopus, Web of Science, Pubmed, Embase,
Scielo, Lilacs. The search was performed from 2010,
since before this date no cases of Hantavirus were
reported in our country. The search strategy used
the following terms DECS and MESH: “Hantavirus”
(Hantavirus), “Roedores” (Rodent diseases), “síndrome
pulmonar por Hantavirus” (Hantavirus Pulmonary
Syndrome), “Fiebre hemorrágica con síndrome renal”
(Hemorrhagic Fever with Renal Syndrome), “Perú”
(Peru), resulting in the following search algorithm
in Spanish: [Hantavirus OR roedores OR síndrome
pulmonar por Hantavirus OR Fiebre hemorrágica
con síndrome renal AND Perú] and in English:
Hantavirus OR Rodent diseases OR Hantavirus
Pulmonary Syndrome OR Hemorrhagic Fever with
Renal Syndrome AND Peru. In addition, it was
complemented by manual search from the relevant
article references to identify possible studies that
were not found in the initial search (snowball search
type) and with the web browser Google Scholar to
incorporate epidemiological reports performed
annually in our country (Figure 1).

Inclusion and exclusion criteria
We included all the published literature that provided
confirmed cases of Hantavirus in our country, as
well as, epidemiological reports that confirmed
cases of Hantavirus, without language restrictions,
study design type and seroprevalence studies on
Hantavirus were excluded since we could not verify
the moment of disease diagnosis.

Article selection
A total of 6 published studies were found in the
electronic databases and 3 epidemiologic reports
were found on Hantavirus during the period from
2010-2020, which constituted our source to obtain
cases with definitive diagnosis through viral RNA
(RT-PCR NESTED) detection, of which a total of 6
cases were obtained from isolated reports: a letter to
the editor that included 2 cases in 2011, in addition a
report of 2 cases during 2011, and 3 epidemiological
reports that included 2 cases during 2012 and 2013
(Figure 1).
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Quality assessment
The quality of the studies included was in relation to
the confirmation of the molecular test for Hantavirus
through the real time polymerase chain reaction (RTPCR).

RESULTS
The general characteristics of the reviewed cases can
be found in Table 1.

Case 2: Female, 33 years of age, professor, from
the district of Punchana-Iquitos, who went to the
emergency room with headache and unspecified
hepatomegaly. After two days, she returns with
abdominal pain in right hypochondrium and
dyspnea. Two days later, she is hospitalized in the
medical department for persistent headaches,
fever, myalgias, hemorrhagic manifestations (upper
GI bleeding and hematuria), acute renal failure
with liver and cardiovascular involvement and
pulmonary damage. She received oxygen therapy
with an unfavorable evolution. She was transferred
to the Intensive Care Unit (ICU) due to increased
respiratory distress and oral and rectal bleeding.
She received hemodialysis but died 6 days after
hospitalization with the diagnoses of multiorgan
failure, septic shock and severe sepsis of unknown
origin, INS determined the presence of IgM
antibodies against Hantavirus through ELISA IgMcapture technique and confirmed the diagnosis
of Hantavirus through RT-PCR. The sequencing
analysis verified genome homology at 97% for
Hantavirus Seoul (AB355731) (5,9,10).
Case 3: Male, 18 years of age, with an initial clinical
presentation of non-quantified hyperthermia,
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Case 1: Female, 20 years of age, from Iquitos, tour guide,
admitted due to lumbar pain, persistent vomiting,
fever, headache and general malaise. The following
presumptive diagnoses were raised: hypovolemia,
non-cardiogenic acute pulmonary, acute renal failure
that required hemodialysis and probable dengue
with alarm signs, patient progressed to respiratory
distress with an adverse prognosis. Patient died
after 23 days of hospitalization with diagnoses of
acute respiratory distress syndrome (ARDS), septic
shock and multiorgan failure. The Instituto Nacional
de Salud (INS) found IgM antibodies against
Hantavirus through ELISA IgM-capture technique
and performed the molecular test for Hantavirus
through RT-PCR. The analysis indicated the presence
of Hantavirus Seoul (AB355731)(5,8-10).

abdominal pain in right hypochondrium, loose
stools without mucus or blood, and progressive
in intensity dry cough. Five days later, he began
to have dyspnea with intercostal retraction in
addition to an episode of porraceous vomiting.
Patient was hospitalized 7 days after disease onset
with por general conditions. Vital functions: 37.5°C
temperature, respiratory rate 38 breaths/min, heart
rate 95 beats/min, blood pressure 100/64 mmHg
and SatO2 92% (FiO2: 0,5). During the clinical exam
we evidenced stupor, pallor, polypnea with perioral
cyanosis, intercostal retractions, bilateral crepitations
in both hemithoraces and hepatosplenomegaly.
Laboratory exams evidenced leukocytosis without
left shift, nitrogen retention and signs of hypoxemic
respiratory failure through arterial gases. Chest
X-ray at the time of hospitalization showed bilateral
multilobe alveolar infiltrates and left apical interstitial
alveolar infiltrates. Twelve hours after being admitted,
the patient underwent a state of shock, inotropes
were initiated (dopamine and dobutamine) with no
response, reason for which adrenaline by infusion
was added. After placing central venous catheter,
patient presented with right hemopneumothorax
followed by profuse bleeding post-thoracic
drainage that required blood transfusion. A hematic
bronchial aspirate was obtained during intubation
for mechanic ventilation support. 48 hours later, he
presented with focalized convulsions in upper right
extremity and anisocoria. The brain tomography
showed intraparenchymal bleeding in both cerebral
hemispheres and subarachnoid hemorrhage. After
72 hours, he presented with acute renal failure.
On the fifth day, we received serologic (ELISA IgM:
1/6400 e IFI IgM: 1/32) and molecular (RT-PCR)
confirmation of Hantavirus. The laboratory studies
for other viruses were negative. The patient died on
the sixth day in ICU due to multiorgan failure. The
phylogenetic analysis of the S genome segment
presented homology at 96% for Rio Mamore virus(6,9).
Case 4: Female, 38 years of age, farmer and housewife
from the Amazon, initiated illness with sensation of
hyperthermia, nausea, epigastric and osteomuscular
pain. Two days later, she presented with vomiting,
loose stools without mucus or blood, in addition
productive cough with green sputum and dyspnea
that progressively intensified in 24 hours. She
was hospitalized 5 days after onset of disease, in
bad general state with a temperature of 36,8 °C,
respiratory rate of 44 breaths/min, SatO2 87,5%
(FiO2: 0,21), heart rate 100 beats/min, blood pressure
95/67mmHg. Clinical exam evidenced intercostal
Pág. 831
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and subcostal retractions and crepitations in both
hemithoraces, and hepatomegaly. The chest X-ray
evidenced a confluence of bilateral multilobar
alveolar infiltrates and left apical alveonodular
infiltrates. Laboratory exams showed leukocytosis
without left shift, nitrogen retention, and the arterial
gases showed signs of hypoxemic respiratory failure.
The criteria of acute respiratory distress syndrome
(ARDS) permitted her admission into ICU where she
received mechanical ventilation. She developed
a state of shock that responded to dobutamine.
In addition, she presented acute renal failure that
required hemodialysis. After 3 days, the serologic
(ELISA IgM: 1/1600 e IFI IgM: 1/16) and molecular
exams confirmed Hantavirus. The patient evolved
favorably and was discharged after 12 days. The
phylogenetic analysis of the S genome segment

Saavedra M et al

presented homology at 96% for the Rio Mamore
virus(6,9).
Cases 5 and 6: Correspond to two cases of feminine
sex, 30 and 40 years of age respectively, from San
Juan Bautista- Maynas, reported in 2012 and 2013,
during epidemiology week 20 and 26. Both patients
presented with moderate dyspnea and were seen in
a referred hospital in the Peruvian jungle, where they
were admitted in Internal Medicine. The Hantavirus
diagnosis was confirmed, in both cases, through
RT-PCR. One of the cases evolved favorably and was
discharged after 7 days, while the other case result
was unknown(9). In the bibliographic search we did
not find official information that gave more details
on the clinical prognosis of these cases.

Figure 1. Flow diagram of literature review on selection of confirmed cases of Hantavirus in Peru.
https://inicib.urp.edu.pe/rfmh/vol21/iss4/19
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Table 1. Epidemiological and clinical characteristics of patients reported with Hantavirus diagnosis in Peru.
Case 2

Case 3

Case 4

Case 5

Case 6

Age and sex

29 years,
femenine

33 years,
femenine

18 years,
masculine

38 years,
femenine

30 years,
femenine

40 years,
femenine

District of
residence

Iquitos

Punchana

Indiana

Mazán

San Juan
Bautista

San Juan
Bautista

Occupation

Tour guide

Professor

Farmer

Farmer/ Housewife

Nurse

Housewife

Clinical form

Pulmonary
syndrome

Hemorrhagic
fever with
renal syndrome

Pulmonary
syndrome

Pulmonary
syndrome

Pulmonary
syndrome

-

Outcome

Died after 23
days since
hospital
admission

Died after 6
days of hospital admission

Discharged
after 12 days
of hospital
admission

Died after 6
days of hospital admission

Discharged
after 7 days
of hospital
admission

-

Diagnostic
methods

ELISA IgM
and RT-PCR
nested in
serum

ELISA IgM
and RT-PCR
nested in
serum

ELISA IgM
and RT-PCR
nested in
serum

ELISA IgM
and RT-PCR
nested in
serum

RT-PCR nested in serum

RT-PCR nested in serum

Genetic sequencing

Variant of
Seoul virus

Variant of
Seoul virus

Río Mamoré
virus

Río Mamoré
virus

Could not
identify

Could not
identify

REVIEW ARTICLE

Case 1

RT-PCR: reverse transcriptase – polymerase chain reaction; ELISA: Enzyme-Linked Inmuno Sorbent Assay; IgM: Immunoglobuline
M; PCR nested in serum: modified PCR technique

Table 2. Clinical characteristics of some tropical diseases with hemorrhagic manifestations.
Disease

Hantavirus

Leptospirosis

Dengue

Yellow fever

Rickettsiosis

14 – 17 days

2 – 26 days

7 – 10 days

3 – 6 days

2 – 14 days

Headache

Yes

Yes

Yes

Yes

Yes

Myalgias

Yes

Yes

Yes

Yes

Yes

Nausea/vomiting

Yes

Yes

Yes

Yes

Yes

Abdominal pain

Yes

Occasional

Occasional

Yes

Yes

Diarrhea

Occasional

No

Occasional

No

Yes

Cough

Occasional

No

No

No

No

Rash

No

Occasional

During the first
3 days

No

After the first
5 days

Jaundice

No

Yes

No

Yes

Yes

Hepatomegaly

Severe cases

Yes

Severe cases

Occasional

Severe cases

Splenomegaly

No

Yes

No

No

No

Severe cases

Severe cases

Severe cases

Severe cases

Severe cases

P. incubation

Hemorrhagic manifestations: Petechiae, purpura

Adapted by: Guzman C, Calderón A, Gonzáles M & Mattar S. Infecciones por hantavirus. Rev. MVZ Córdoba. 2017; 22:6101-6117.
DOI: 10.21897/rmvz.1079
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Confirmed cases by Hantavirus according to scientific publications between 2010-2020 observed in the districts of Indiana,
Iquitos, Mazan, Punchana and San Juan Bautista, belonging to the province of Maynas in the department of Loreto.
Source: Compilation

Figure 2. Distribution of confirmed cases of Hantavirus according to publications, 2010-2020.
DISCUSSION
In Peru, Hantavirosis has been present in inhabitants
of the Amazonian jungle of Loreto in the severe
clinical form with a death rate of 40–60%(11), as well
as in its mild and self-limiting forms(12,13).
In America, several types of Hantavirus exist that
cause disease in humans, whether as a severe/ deadly
or mild/asymptomatic disease. Likewise, it has been
identified in different types of rodents(11,12,14), with
Hantaan (HTNV), Laguna Negra (LNV), Sin nombre
(SNV), Río Mamore (RIOMV) and Virus Seoul, as
the types most reported in various studies in our
country(9,12,14). This study shows the Seoul virus as
the cause of lethal disease (2 cases) and RIOMV as
the cause of severe disease with discharge (1 case)
and fatal outcome (1 case), while in the other 2
cases the type of Hantavirus could not be identified.
Diverse seroprevalence studies performed in Loreto
have reported that HTNV, LNV, SNV and RIOMV are
the causes of mild and self-limiting disease(5,6,9,12).
In addition, they show a prevalence of 20% of IgG
to Hantavirus in rodents(13), a prevalence of 1,7% of
IgG in humans(12), while the prevalence of IgM was
0.3% in febrile patients with mild disease(6). However,
the possibility exists that other regions of Peru may
https://inicib.urp.edu.pe/rfmh/vol21/iss4/19
Pág. 834
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be exposed to the viral reservoir, such as is the case
in the San Martin region in the Alto Mayo Valley,
where an asymptomatic case was detected with IgM
antibodies specific to Hantavirus in 250 rice farmers
exposed to rodents(15).
The cases presented in this series meet the definition
of HPS cases proposed by the CDC in 2015(16): fever,
headache, gastrointestinal symptoms, pneumonia
with no obvious etiology, cough, cyanosis, severe
acute respiratory failure and alveolar or bilateral
interstitial infiltrates compatible with acute
respiratory distress syndrome (ARDS) and required
Intensive Care Unit (ICU) care, in other words an acute
febrile case with torpid evolution and multiorgan
failure with a fatal prognosis in most cases. While
in laboratory exams, leukocytosis without left shift,
mild thrombocytopenia, increase in hematocrit,
creatinine and urea were found. The confirmed
diagnosis of Hantavirus was obtained (2 were Seoul
virus and 2 Mamore virus) through the detection of
specific antibodies (ELISA IgM and IgG) and/or viral
RNA (RT-PCR NESTED) in a specialized establishment
(Instituto Nacional de Salud). It is known that
the specific etiological diagnosis is difficult, due
to the existing crossed reactions with the viral
variants(11). Likewise, it is important to remember
6
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that Hantavirosis are unattended infectious diseases
in Peru, since it occurs in poor populations and in
isolated geographical areas, reason for which there
is a sub-registration of disease and lack of diagnostic
tests(17).
Unfortunately, we do not have a specific treatment
or vaccine against Hantavirus infection, which is
why it is important to receive support therapy
based on good hydration, antipyretic and antiinflammatory drugs is the only therapeutic option at
the moment(16,18).

CONCLUSION
In conclusion, Hantavirosis is a viral disease without
a definitive treatment. In Peru, the reported cases are
few and possibly sub-registered in comparison to
other countries in Latin America. We must strengthen
the diagnostic studies in humans as well as animals,
with the objective to improve the suspicion and
identification of this infection in all at risk groups and
therefore decrease mortality rates.
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On the other hand, the early diagnosis of severe cases
and their transfer to ICU is associated with a reduction
in mortality. Likewise, the initial clinical signs do
not differentiate from other viral diseases, which is
why the molecular or immunological confirmatory
diagnosis is crucial(18). In the same manner, every

patient with acute febrile symptoms from an
endemic zone for Hantavirus, should be treated as a
suspected case, requiring to rule out other tropical
diseases with hemorrhagic manifestations, such as
dengue, yellow fever, Rickettsiosis and Leptospirosis
(Table 2)(18).
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